Long-term outcomes of the iFCG regimen for firstline treatment of patients with IGHV-mutated CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:43 1 year ago 56 Далее Скачать
iFCG for first-line treatment of IGHV-mutated CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:32 5 years ago 361 Далее Скачать
iFCG: a promising new regimen for treating IGHV-mutated CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:35 7 years ago 349 Далее Скачать
iFCG proves promising for IGHV-mutated CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:46 4 years ago 203 Далее Скачать
Long-term outcomes of patients with CLL treated with continuous ibrutinib VJHemOnc – Video Journal of Hematology & HemOnc 1:05 1 year ago 1 137 Далее Скачать
Considerations of Ibrutinib for IgHV-Unmutated CLL Targeted Oncology 5:30 5 years ago 460 Далее Скачать
Should standard chemotherapy regimens be altered in favor of small molecules? iFCG for frontline CLL VJHemOnc – Video Journal of Hematology & HemOnc 3:15 6 years ago 178 Далее Скачать
Reducing the risks of chemotherapy in IGHV-mutated CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:59 7 years ago 494 Далее Скачать
Long-term outcomes and toxicities of ibrutinib in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:22 1 year ago 327 Далее Скачать
Selecting First-Line Treatment for Chronic Lymphocytic Leukemia (CLL) OncLive 12:53 9 years ago 9 599 Далее Скачать
Ibrutinib and FCR in CLL irrespective of IGHV mutation status VJHemOnc – Video Journal of Hematology & HemOnc 1:44 2 years ago 289 Далее Скачать
Novel approaches to first line CLL treatment VJHemOnc – Video Journal of Hematology & HemOnc 2:14 6 years ago 207 Далее Скачать
IGHV-Mutated vs IGHV-Unmutated CLL | What’s the Difference? Patient Empowerment Network 5:03 1 year ago 1 192 Далее Скачать
The impact of IGHV mutational status in treatment decisions in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:50 2 years ago 453 Далее Скачать
Online webinar - Chronic Lymphocytic Leukaemia (CLL) first-line treatment Leukaemia Care 1:28:10 3 years ago 1 000 Далее Скачать
The long-term efficacy of acalabrutinib-based regimens in patients with CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:29 2 years ago 1 620 Далее Скачать
Clinical outcomes of patients with CLL receiving long-term ibrutinib in the RESONATE-2 study VJHemOnc – Video Journal of Hematology & HemOnc 2:55 2 years ago 125 Далее Скачать
The latest CLL treatments and therapies with Dr Jan Burger Leukaemia Foundation - Blood Cancer Information 50:25 5 years ago 2 820 Далее Скачать
